N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications

N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications

Cancer therapy resistance (CTR) is the development of cancer resistance to multiple therapeutic strategies, which severely affects clinical response and leads to cancer progression, recurrence, and metastasis. N6-methyladenosine (m6A) has been identified as the most common, abundant, and conserved i...

Full description

Bibliographic Details
Main Authors: Dong Wang, Yan Zhang, Qingbo Li, Ao Zhang, Jingxuan Xu, Yu Li, Wen Li, Lin Tang, Fan Yang, Jingyan Meng
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Cancer
N6-methyladenosine
RNA metabolism
Therapeutic resistance
Epigenetics
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223012751

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223012751

Similar Items